Products

View as  
 
Tofacitinib

Tofacitinib

Product Name:Tofacitinib
Molecular Formula:C16H20N6O
Molecular Weight;312.38
CAS Registry Number;477600-75-2

Read MoreSend Inquiry
4-Chloropyrrolo[2,3-d]Pyrimidine

4-Chloropyrrolo[2,3-d]Pyrimidine

Product Name:4-Chloropyrrolo[2,3-d]Pyrimidine
Molecular Formula:C6H4ClN3
Molecular Weight:153.57
CAS Registry Number:3680-69-1

Read MoreSend Inquiry
(3R,4R)-N,4-Dimethyl-1-(Phenylmethyl)-3-Piperidinamine Hydrochloride

(3R,4R)-N,4-Dimethyl-1-(Phenylmethyl)-3-Piperidinamine Hydrochloride

Product ​Name:(3R,4R)-N,4-Dimethyl-1-(Phenylmethyl)-3-Piperidinamine Hydrochloride
Molecular Formula:C14H22N2.2(HCl)
Molecular Weight:291.26
CAS NO:1062580-52-2
Usage:Tofacitinib Citrate

Read MoreSend Inquiry
Tofacitinib Citrate

Tofacitinib Citrate

Name:Tofacitinib Citrate
Molecular Formula:C16H20N6O.C6H8O7
Molecular Weight:504.50
CAS NO:540737-29-9
Usage:Tofacitinib Citrate

Read MoreSend Inquiry
4-Chloro-7-Tosyl-7H-Pyrrolo[2,3-d]Pyrimidine

4-Chloro-7-Tosyl-7H-Pyrrolo[2,3-d]Pyrimidine

Product ​Name:4-Chloro-7-Tosyl-7H-Pyrrolo[2,3-d]Pyrimidine
Synonyms:4-Chloro-7-(4-methylphenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimidine
Molecular Formula:C13H10ClN3O2S
Molecular Weight:307.76
CAS NO:479633-63-1
Usage:Tofacitinib Citrate

Read MoreSend Inquiry
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-Pyrrolo[2,3-d]PyriMidin-4-AMine Dihydrochloride

N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-Pyrrolo[2,3-d]PyriMidin-4-AMine Dihydrochloride

Product Name:N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-Pyrrolo[2,3-d]PyriMidin-4-AMine Dihydrochloride
Molecular Formula:C13H19N5.HCl
Molecular Weight:281.78
CAS Registry Number:1260590-51-9

Read MoreSend Inquiry
China Tofacitinib manufacturers and suppliers - Sandoo.Welcome to wholesale Tofacitinib from our factory, We hope we can bring you the best quality in China and bring the customer more safety and more reliable products.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept